Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis

Fimasartan, a new angiotensin II receptor antagonist, reduces myocyte damage and stabilizes atherosclerotic plaque through its anti-inflammatory effect in animal studies. We investigated the protective effects of pretreatment with fimasartan on ischemia-reperfusion injury (IRI) in a mouse model of i...

詳細記述

保存先:
書誌詳細
出版年:Korean J Physiol Pharmacol
主要な著者: Cho, Jang-Hee, Choi, Soon-Youn, Ryu, Hye-Myung, Oh, Eun-Joo, Yook, Ju-Min, Ahn, Ji-Sun, Jung, Hee-Yeon, Choi, Ji-Young, Park, Sun-Hee, Kim, Chan-Duck, Kim, Yong-Lim
フォーマット: Artigo
言語:Inglês
出版事項: The Korean Physiological Society and The Korean Society of Pharmacology 2018
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205936/
https://ncbi.nlm.nih.gov/pubmed/30402026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2018.22.6.661
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料